Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Clin Infect Dis ; 76(3): e1236-e1243, 2023 02 08.
Article in English | MEDLINE | ID: mdl-35684979

ABSTRACT

BACKGROUND: Extraintestinal pathogenic Escherichia coli (ExPEC) is the leading cause of bacteremia worldwide, with older populations having increased risk of invasive bacterial disease. Increasing resistance to first-line antibiotics and emergence of multidrug-resistant (MDR) strains represent major treatment challenges. ExPEC O serotypes are key targets for potential multivalent conjugate vaccine development. Therefore, we evaluated the O serotype distribution and antibiotic resistance profiles of ExPEC strains causing bloodstream infections across 4 regions. METHODS: Blood culture isolates from patients aged ≥60 years collected during 5 retrospective E. coli surveillance studies in Europe, North America, Asia-Pacific, and South America (2011-2017) were analyzed. Isolates were O serotyped by agglutination; O genotyping was performed for nontypeable isolates. Antimicrobial susceptibility testing was also conducted. RESULTS: Among 3217 ExPEC blood culture isolates, the most ubiquitous O serotype was O25 (n = 737 [22.9%]), followed by O2, O6, O1, O75, O15, O8, O16, O4, O18, O77 group, O153, O9, O101/O162, O86, and O13 (prevalence of ≥1%). The prevalence of these O serotypes was generally consistent across regions, apart from South America; together, these 16 O serotypes represented 77.6% of all ExPEC bacteremia isolates analyzed. The overall MDR frequency was 10.7%, with limited variation between regions. Within the MDR subset (n = 345), O25 showed a dominant prevalence of 63.2% (n = 218). CONCLUSIONS: Predominant O serotypes among ExPEC bacteremia isolates are widespread across different regions. O25 was the most prevalent O serotype overall and particularly dominant among MDR isolates. These findings may inform the design of multivalent conjugate vaccines that can target the predominant O serotypes associated with invasive ExPEC disease in older adults.


Subject(s)
Bacteremia , Escherichia coli Infections , Extraintestinal Pathogenic Escherichia coli , Humans , Aged , Extraintestinal Pathogenic Escherichia coli/genetics , Escherichia coli , Serogroup , Retrospective Studies , Escherichia coli Infections/epidemiology , Escherichia coli Infections/microbiology , Bacteremia/epidemiology , Drug Resistance, Microbial
2.
J Infect Chemother ; 28(11): 1445-1451, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35843539

ABSTRACT

INTRODUCTION: Invasive extraintestinal pathogenic Escherichia coli (ExPEC) disease (IED), characterised by sepsis and bacteraemia, is a major global healthcare concern worsened by emerging multidrug resistant (MDR) strains. The development of multivalent prophylactic vaccines targeting E. coli strains of IED-associated O-serotypes could address this. A better understanding of O-serotype distribution is required for this purpose. Here, we characterised O-serotype prevalence and drug resistance among ExPEC bacteraemia isolates in Japan. METHODS: E. coli blood isolates from patients aged ≥60 years with bacteraemia were obtained from a retrospective surveillance study in Japan (2015-2017). O-serotyping was performed by agglutination; for isolates non-typeable by agglutination, O-genotyping was performed. Antimicrobial susceptibility was evaluated by broth microdilution using a 21-antibiotic panel. The frequency of drug resistant (DR) isolates was evaluated by antimicrobial susceptibility testing. RESULTS: Of 401 ExPEC bacteraemia isolates evaluated, the most prevalent O-serotype (≥1%) was O25 (28.7% [n = 115]), followed by O1 (14.2% [n = 57]), O2 (8.5% n = 34]), O6 (5.5% [n = 22]), O75, O18, O13, O16, O15, O4, O46/O134, O86, O8 and O83 (each <5% prevalence). These 14 O-serotypes accounted for 81.5% of isolates collected. In total, 19% (n = 77) of isolates were DR ≥ 3, of which 59.7% were O25. Fluoroquinolone-resistance among all and O25 isolates was most prevalent (35.7% and 84.3%, respectively). Almost all (98%) isolates identified as O25 were of subtype O25B. CONCLUSIONS: E. coli serotype O25B showed the highest prevalence and highest multidrug resistance among ExPEC bacteraemia isolates from patients ≥60 years in Japan. Our data may inform development of multivalent glycoconjugate vaccines to prevent IED.


Subject(s)
Anti-Infective Agents , Bacteremia , Escherichia coli Infections , Extraintestinal Pathogenic Escherichia coli , Vaccines , Bacteremia/epidemiology , Drug Resistance, Microbial , Escherichia coli , Escherichia coli Infections/drug therapy , Escherichia coli Infections/epidemiology , Extraintestinal Pathogenic Escherichia coli/genetics , Humans , Japan/epidemiology , Retrospective Studies , Serogroup , Serotyping
3.
FEMS Microbiol Rev ; 46(6)2022 11 02.
Article in English | MEDLINE | ID: mdl-35749579

ABSTRACT

Escherichia coli is the most researched microbial organism in the world. Its varied impact on human health, consisting of commensalism, gastrointestinal disease, or extraintestinal pathologies, has generated a separation of the species into at least eleven pathotypes (also known as pathovars). These are broadly split into two groups, intestinal pathogenic E. coli (InPEC) and extraintestinal pathogenic E. coli (ExPEC). However, components of E. coli's infinite open accessory genome are horizontally transferred with substantial frequency, creating pathogenic hybrid strains that defy a clear pathotype designation. Here, we take a birds-eye view of the E. coli species, characterizing it from historical, clinical, and genetic perspectives. We examine the wide spectrum of human disease caused by E. coli, the genome content of the bacterium, and its propensity to acquire, exchange, and maintain antibiotic resistance genes and virulence traits. Our portrayal of the species also discusses elements that have shaped its overall population structure and summarizes the current state of vaccine development targeted at the most frequent E. coli pathovars. In our conclusions, we advocate streamlining efforts for clinical reporting of ExPEC, and emphasize the pathogenic potential that exists throughout the entire species.


Subject(s)
Escherichia coli Infections , Escherichia coli Proteins , Extraintestinal Pathogenic Escherichia coli , Humans , Escherichia coli/genetics , Escherichia coli Infections/microbiology , Extraintestinal Pathogenic Escherichia coli/genetics , Escherichia coli Proteins/genetics , Genomics , Virulence Factors/genetics , Phylogeny
4.
PLoS One ; 14(1): e0211003, 2019.
Article in English | MEDLINE | ID: mdl-30673778

ABSTRACT

The mycobacterial type VII secretion system ESX-1 is responsible for the secretion of a number of proteins that play important roles during host infection. The regulation of the expression of secreted proteins is often essential to establish successful infection. Using transcriptome sequencing, we found that the abrogation of ESX-1 function in Mycobacterium marinum leads to a pronounced increase in gene expression levels of the espA operon during the infection of macrophages. In addition, the disruption of ESX-1-mediated protein secretion also leads to a specific down-regulation of the ESX-1 substrates, but not of the structural components of this system, during growth in culture medium. This effect is observed in both M. marinum and M. tuberculosis. We established that down-regulation of ESX-1 substrates is the result of a regulatory process that is influenced by the putative transcriptional regulator whib6, which is located adjacent to the esx-1 locus. In addition, the overexpression of the ESX-1-associated PE35/PPE68 protein pair resulted in a significantly increased secretion of the ESX-1 substrate EsxA, demonstrating a functional link between these proteins. Taken together, these data show that WhiB6 is required for the secretion-dependent regulation of ESX-1 substrates and that ESX-1 substrates are regulated independently from the structural components, both during infection and as a result of active secretion.


Subject(s)
Antigens, Bacterial , Bacterial Proteins , Down-Regulation , Gene Expression Regulation, Bacterial , Mycobacterium marinum , Mycobacterium tuberculosis , Transcriptome , Antigens, Bacterial/genetics , Antigens, Bacterial/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Humans , Mutation , Mycobacterium marinum/genetics , Mycobacterium marinum/metabolism , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/metabolism , THP-1 Cells
6.
PLoS One ; 10(6): e0126378, 2015.
Article in English | MEDLINE | ID: mdl-26083432

ABSTRACT

Adaptive immunity in homeotherms depends greatly on CD4+ Th cells which release cytokines in response to specific antigen stimulation. Whilst bony fish and poikilothermic tetrapods possess cells that express TcR and CD4-related genes (that exist in two forms in teleost fish; termed CD4-1 and CD4-2), to date there is no unequivocal demonstration that cells equivalent to Th exist. Thus, in this study we determined whether CD4-1+ lymphocytes can express cytokines typical of Th cells following antigen specific stimulation, using the zebrafish (Danio rerio). Initially, we analyzed the CD4 locus in zebrafish and found three CD4 homologues, a CD4-1 molecule and two CD4-2 molecules. The zfCD4-1 and zfCD4-2 transcripts were detected in immune organs and were most highly expressed in lymphocytes. A polyclonal antibody to zfCD4-1 was developed and used with an antibody to ZAP70 and revealed double positive cells by immunohistochemistry, and in the Mycobacterium marinum disease model CD4-1+ cells were apparent surrounding the granulomas typical of the infection. Next a prime-boost experiment, using human gamma globulin as antigen, was performed and revealed for the first time in fish that zfCD4-1+ lymphocytes increase the expression of cytokines and master transcription factors relevant to Th1/Th2-type responses as a consequence of boosting with specific antigen.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Cytokines/biosynthesis , Histocompatibility Antigens Class II/immunology , Mycobacterium Infections, Nontuberculous/immunology , Mycobacterium Infections, Nontuberculous/veterinary , RNA, Messenger/immunology , Adaptive Immunity , Amino Acid Sequence , Animals , Antibodies/chemistry , CD4-Positive T-Lymphocytes/classification , CD4-Positive T-Lymphocytes/microbiology , CD4-Positive T-Lymphocytes/pathology , Cytokines/immunology , Genetic Loci/immunology , Histocompatibility Antigens Class II/genetics , Humans , Models, Molecular , Molecular Sequence Data , Mycobacterium Infections, Nontuberculous/genetics , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium marinum/immunology , Phylogeny , RNA, Messenger/genetics , Sequence Alignment , Th1-Th2 Balance , ZAP-70 Protein-Tyrosine Kinase/genetics , ZAP-70 Protein-Tyrosine Kinase/immunology , Zebrafish/classification , Zebrafish/genetics , Zebrafish/immunology , Zebrafish Proteins/genetics , Zebrafish Proteins/immunology , gamma-Globulins/administration & dosage
7.
PLoS Genet ; 11(5): e1005190, 2015 May.
Article in English | MEDLINE | ID: mdl-25938982

ABSTRACT

Mycobacteria possess different type VII secretion (T7S) systems to secrete proteins across their unusual cell envelope. One of these systems, ESX-5, is only present in slow-growing mycobacteria and responsible for the secretion of multiple substrates. However, the role of ESX-5 substrates in growth and/or virulence is largely unknown. In this study, we show that esx-5 is essential for growth of both Mycobacterium marinum and Mycobacterium bovis. Remarkably, this essentiality can be rescued by increasing the permeability of the outer membrane, either by altering its lipid composition or by the introduction of the heterologous porin MspA. Mutagenesis of the first nucleotide-binding domain of the membrane ATPase EccC5 prevented both ESX-5-dependent secretion and bacterial growth, but did not affect ESX-5 complex assembly. This suggests that the rescuing effect is not due to pores formed by the ESX-5 membrane complex, but caused by ESX-5 activity. Subsequent proteomic analysis to identify crucial ESX-5 substrates confirmed that all detectable PE and PPE proteins in the cell surface and cell envelope fractions were routed through ESX-5. Additionally, saturated transposon-directed insertion-site sequencing (TraDIS) was applied to both wild-type M. marinum cells and cells expressing mspA to identify genes that are not essential anymore in the presence of MspA. This analysis confirmed the importance of esx-5, but we could not identify essential ESX-5 substrates, indicating that multiple of these substrates are together responsible for the essentiality. Finally, examination of phenotypes on defined carbon sources revealed that an esx-5 mutant is strongly impaired in the uptake and utilization of hydrophobic carbon sources. Based on these data, we propose a model in which the ESX-5 system is responsible for the transport of cell envelope proteins that are required for nutrient uptake. These proteins might in this way compensate for the lack of MspA-like porins in slow-growing mycobacteria.


Subject(s)
Bacterial Proteins/metabolism , Gene Expression Regulation, Bacterial , Mycobacterium bovis/genetics , Mycobacterium marinum/genetics , Type VII Secretion Systems/metabolism , Ampicillin/pharmacology , Bacterial Proteins/genetics , Cell Membrane Permeability , Chromatography, Liquid , DNA Transposable Elements , DNA, Bacterial/genetics , Drug Resistance, Bacterial , Mutation , Mycobacterium bovis/metabolism , Mycobacterium marinum/metabolism , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/metabolism , Sequence Analysis, DNA , Tandem Mass Spectrometry , Type VII Secretion Systems/genetics
8.
Infect Immun ; 83(5): 1778-88, 2015 May.
Article in English | MEDLINE | ID: mdl-25690095

ABSTRACT

The interaction of environmental bacteria with unicellular eukaryotes is generally considered a major driving force for the evolution of intracellular pathogens, allowing them to survive and replicate in phagocytic cells of vertebrate hosts. To test this hypothesis on a genome-wide level, we determined for the intracellular pathogen Mycobacterium marinum whether it uses conserved strategies to exploit host cells from both protozoan and vertebrate origin. Using transposon-directed insertion site sequencing (TraDIS), we determined differences in genetic requirements for survival and replication in phagocytic cells of organisms from different kingdoms. In line with the general hypothesis, we identified a number of general virulence mechanisms, including the type VII protein secretion system ESX-1, biosynthesis of polyketide lipids, and utilization of sterols. However, we were also able to show that M. marinum contains an even larger set of host-specific virulence determinants, including proteins involved in the modification of surface glycolipids and, surprisingly, the auxiliary proteins of the ESX-1 system. Several of these factors were in fact counterproductive in other hosts. Therefore, M. marinum contains different sets of virulence factors that are tailored for specific hosts. Our data imply that although amoebae could function as a training ground for intracellular pathogens, they do not fully prepare pathogens for crossing species barriers.


Subject(s)
Genome, Bacterial , Microbial Viability , Mutagenesis, Insertional , Mycobacterium marinum/genetics , Mycobacterium marinum/physiology , Virulence Factors/metabolism , Acanthamoeba castellanii/microbiology , Animals , DNA Transposable Elements , Dictyostelium/microbiology , Humans , Mycobacterium marinum/growth & development , Phagocytes/microbiology , Virulence , Virulence Factors/genetics
9.
Cell Microbiol ; 14(5): 728-39, 2012 May.
Article in English | MEDLINE | ID: mdl-22256857

ABSTRACT

ESX-5 is a mycobacterial type VII protein secretion system responsible for transport of numerous PE and PPE proteins. It is involved in the induction of host cell death and modulation of the cytokine response in vitro. In this work, we studied the effects of ESX-5 in embryonic and adult zebrafish using Mycobacterium marinum. We found that ESX-5-deficient M. marinum was slightly attenuated in zebrafish embryos. Surprisingly, the same mutant showed highly increased virulence in adult zebrafish, characterized by increased bacterial loads and early onset of granuloma formation with rapid development of necrotic centres. This early onset of granuloma formation was accompanied by an increased expression of pro-inflammatory cytokines and tissue remodelling genes in zebrafish infected with the ESX-5 mutant. Experiments using RAG-1-deficient zebrafish showed that the increased virulence of the ESX-5 mutant was not dependent on the adaptive immune system. Mixed infection experiments with wild-type and ESX-5 mutant bacteria showed that the latter had a specific advantage in adult zebrafish and outcompeted wild-type bacteria. Together our experiments indicate that ESX-5-mediated protein secretion is used by M. marinum to establish a moderate and persistent infection.


Subject(s)
Gene Deletion , Host-Pathogen Interactions , Mycobacterium marinum/genetics , Mycobacterium marinum/pathogenicity , Virulence Factors/genetics , Virulence Factors/metabolism , Zebrafish/microbiology , Animals , Bacterial Load , Cytokines/biosynthesis , Gene Expression Profiling , Granuloma/pathology , Necrosis/pathology , Virulence
10.
Trends Microbiol ; 18(1): 1-10, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19962899

ABSTRACT

CD8(+) T cells are activated upon presentation of antigens from the cytosol. Therefore, it was unclear how pathogenic mycobacteria could prime this type of lymphocyte, given that these microbes were thought to remain in phagosomes and, hence, be shielded from the host cytosol. Recently, it was shown that some mycobacteria can enter the cytosol through translocation from phagolysosomes, providing a direct mechanism for CD8(+) T cell priming. However, this mechanism might not apply to other mycobacteria, which do not appear to be able to enter the cytosol. Here, we discuss the different hypotheses to explain the induction of CD8(+) T cell responses in mycobacterial infections.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Mycobacterium Infections/immunology , Mycobacterium/immunology , Animals , Antigen Presentation/immunology , Antigens, Bacterial/immunology , Cytosol/immunology , Cytosol/microbiology , Homeodomain Proteins/immunology , Host-Pathogen Interactions/immunology , Humans , Lymphocyte Activation , Mycobacterium bovis/immunology
11.
Mol Microbiol ; 73(3): 329-40, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19602152

ABSTRACT

ESX-5 is one of the five type VII secretion systems found in mycobacteria. These secretion systems are also known as ESAT-6-like secretion systems. Here, we have determined the secretome of ESX-5 by a proteomic approach in two different strains of Mycobacterium marinum. Comparison of the secretion profile of wild-type strains and their ESX-5 mutants showed that a number of PE_PGRS and PPE-MPTR proteins are dependent on ESX-5 for transport. The PE and PPE protein families are unique to mycobacteria, are highly expanded in several pathogenic species, such as Mycobacterium tuberculosis and M. marinum, and certain family members are cell surface antigens associated with virulence. Using a monoclonal antibody directed against the PGRS domain we showed that nearly all PE_PGRS proteins that are recognized by this antibody are missing in the supernatant of ESX-5 mutants. In addition to PE_PGRS and PPE proteins, the ESX-5 secretion system is responsible for the secretion of a ESAT-6-like proteins. Together, these data show that ESX-5 is probably a major secretion pathway for mycobacteria and that this system is responsible for the secretion of recently evolved PE_PGRS and PPE proteins.


Subject(s)
Bacterial Proteins/metabolism , Membrane Proteins/metabolism , Mycobacterium marinum/metabolism , Proteome , Antigens, Bacterial/genetics , Bacterial Proteins/genetics , Cloning, Molecular , DNA, Bacterial/genetics , Genes, Bacterial , Genetic Complementation Test , Genome, Bacterial , Membrane Proteins/genetics , Mycobacterium marinum/genetics , Secretory Pathway
12.
J Infect Dis ; 198(6): 928-36, 2008 Sep 15.
Article in English | MEDLINE | ID: mdl-18684097

ABSTRACT

BACKGROUND: Pregnancy-associated malaria is known to modify fetal immunity. Most previous studies have been cross-sectional in nature and have focused on the priming of acquired immune responses in utero. In this context, the influence of the timing and/or duration of placental infection with Plasmodium falciparum are unknown, and changes to innate immune responses have not been studied extensively. METHODS: Pregnant women in Gabon, where P. falciparum infection is endemic, were followed up through monthly clinical and parasitological examinations from the second trimester to delivery. Cells of neonates born to mothers who had acquired P. falciparum infection

Subject(s)
Cytokines/blood , Malaria/complications , Malaria/physiopathology , Pregnancy Complications, Infectious/parasitology , Toll-Like Receptors/physiology , Adult , Birth Weight , Female , Fetal Blood , Humans , Infant, Newborn , Ligands , Parity , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...